Literature DB >> 16954338

Population approaches to estimate minimal model indexes of insulin sensitivity and glucose effectiveness using full and reduced sampling schedules.

Kevin M Krudys1, Steven E Kahn, Paolo Vicini.   

Abstract

The intravenous glucose tolerance test (IVGTT) interpreted with the minimal model provides individual indexes of insulin sensitivity (S(I)) and glucose effectiveness (S(G)). In population studies, the traditional approach, the standard two-stage (STS) method, fails to account for uncertainty in individual estimates, resulting in an overestimation of between-subject variability. Furthermore, in the presence of reduced sampling and/or insulin resistance, individual estimates may be unobtainable, biasing population information. Therefore, we investigated the use of two population approaches, the iterative two-stage (ITS) method and nonlinear mixed-effects modeling (NM), in a population (n = 235) of insulin-sensitive and insulin-resistant subjects under full (FSS, 33 samples) and reduced [RSS(240-min), 13 samples and RSS(180-min), 12 samples] IVGTT sampling schedules. All three population methods gave similar results with the FSS. Using RSS(240), the three methods gave similar results for S(I), but S(G) population means were overestimated. With RSS(180), S(I) and S(G) population means were higher for all three methods compared with their FSS counterparts. NM estimated similar between-subject variability (19% S(G), 53% S(I)) with RSS(180), whereas ITS showed regression to the mean for S(G) (0.01% S(G), 56% S(I)) and STS provided larger population variability in S(I) (29% S(G), 91% S(I)). NM provided individual estimates for all subjects, whereas the two-stage methods failed in 16-18% of the subjects using RSS(180) and 6-14% using RSS(240). We conclude that population approaches, specifically NM, are useful in studies with a sparsely sampled IVGTT ( approximately 12 samples) of short duration ( approximately 3 h) and when individual parameter estimates in all subjects are desired.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954338     DOI: 10.1152/ajpendo.00346.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  9 in total

1.  An improved nonlinear model describing the hepatic pharmacokinetics of digoxin: evidence for two functionally different uptake systems and saturable binding.

Authors:  Michael Weiss; Peng Li; Michael S Roberts
Journal:  Pharm Res       Date:  2010-07-13       Impact factor: 4.200

2.  Design and clinical pilot testing of the model-based dynamic insulin sensitivity and secretion test (DISST).

Authors:  Thomas F Lotz; J Geoffrey Chase; Kirsten A McAuley; Geoffrey M Shaw; Paul D Docherty; Juliet E Berkeley; Sheila M Williams; Christopher E Hann; Jim I Mann
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

3.  Modeling changes in glucose and glycerol rates of appearance when true basal rates of appearance cannot be readily determined.

Authors:  Laura Pyle; Bryan C Bergman; Kristen J Nadeau; Melanie Cree-Green
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-29       Impact factor: 4.310

4.  Myocardial pharmacokinetics of ebastine, a substrate for cytochrome P450 2J, in rat isolated heart.

Authors:  W Kang; S Elitzer; K Noh; T Bednarek; M Weiss
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  Adjusting glucose-stimulated insulin secretion for adipose insulin resistance: an index of β-cell function in obese adults.

Authors:  Steven K Malin; Sangeeta R Kashyap; Jeff Hammel; Yoshi Miyazaki; Ralph A DeFronzo; John P Kirwan
Journal:  Diabetes Care       Date:  2014-08-19       Impact factor: 19.112

6.  Nonlinear modeling of the dynamic effects of infused insulin on glucose: comparison of compartmental with Volterra models.

Authors:  Georgios D Mitsis; Mihalis G Markakis; Vasilis Z Marmarelis
Journal:  IEEE Trans Biomed Eng       Date:  2009-06-02       Impact factor: 4.538

7.  Validity of the reduced-sample insulin modified frequently-sampled intravenous glucose tolerance test using the nonlinear regression approach.

Authors:  Anne E Sumner; Marcella F Luercio; Barbara A Frempong; Madia Ricks; Sabyasachi Sen; Harvey Kushner; Marshall K Tulloch-Reid
Journal:  Metabolism       Date:  2009-02       Impact factor: 8.694

8.  IVGTT glucose minimal model covariate selection by nonlinear mixed-effects approach.

Authors:  Paolo Denti; Alessandra Bertoldo; Paolo Vicini; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-01-26       Impact factor: 4.310

9.  The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes.

Authors:  Nor Azlan Othman; Paul D Docherty; Jeremy D Krebs; Damon A Bell; J Geoffrey Chase
Journal:  Biomed Eng Online       Date:  2015-03-03       Impact factor: 2.819

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.